Rigel's CEO to Participate in Panel Discussion at Citi's 14th Annual Biotech Conference Aug 28, 2019 7:30am EDT
Rigel Announces Second Quarter 2019 Financial Results and Provides Business Update Aug 06, 2019 4:01pm EDT
Rigel Announces Conference Call and Webcast to Report Second Quarter 2019 Financial Results Jul 30, 2019 7:30am EDT
Rigel to Present Two Posters Highlighting Fostamatinib at the 24ᵗʰ Congress of the European Hematology Association (EHA) Jun 13, 2019 7:30am EDT
Rigel Enrolls First Patient in Phase 3 Clinical Trial of Fostamatinib Disodium Hexahydrate in Warm Autoimmune Hemolytic Anemia May 16, 2019 7:30am EDT
Rigel Announces First Quarter 2019 Financial Results and Provides Company Update May 07, 2019 4:01pm EDT
Rigel Announces Conference Call and Webcast to Report First Quarter 2019 Financial Results and Company Update Apr 30, 2019 7:30am EDT
Rigel Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update Feb 28, 2019 4:01pm EST
